Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model

J Xu, E Torres, AL Mora, H Shim, A Ramirez… - The Journal of heart and …, 2008 - Elsevier
BACKGROUND: Long-term success in lung transplantation is limited by obliterative
bronchiolitis (OB), yet the mechanism for this disease is not well understood. Chemokine …

Attenuation of Obliterative Bronchiolitis by a CXCR4 Antagonist in the Murine Heterotopic Tracheal Transplant Model

J Xu, E Torres, AL Mora, H Shim, A Ramirez… - The Journal of Heart …, 2008 - jhltonline.org
Background Long-term success in lung transplantation is limited by obliterative bronchiolitis
(OB), yet the mechanism for this disease is not well understood. Chemokine SDF-1 and its …

Attenuation of Obliterative Bronchiolitis by a CXCR4 Antagonist in the Murine Heterotopic Tracheal Transplant Model

JG Xu, E Torres, AL Mora, HS Shim… - Journal of Heart and …, 2008 - hero.epa.gov
Background: Long-term success in lung transplantation is limited by obliterative bronchiolitis
(OB), yet the mechanism for this disease is not well understood. Chemokine SDF-1 and its …

Attenuation of Obliterative Bronchiolitis by a CXCR4 Antagonist in the Murine Heterotopic Tracheal Transplant Model

J Xu, E Torres, AL Mora, H Shim, A Ramirez… - Journal of Heart and …, 2008 - infona.pl
Long-term success in lung transplantation is limited by obliterative bronchiolitis (OB), yet the
mechanism for this disease is not well understood. Chemokine SDF-1 and its receptor …

[PDF][PDF] Attenuation of Obliterative Bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model

J Xu, E Torres, A Mora, H Shim, A Ramirez… - J Heart Lung …, 2008 - academia.edu
Long-term success in lung transplantation is limited by obliterative bronchiolits (OB), while
the mechanism for this disease is not well-understood. Chemokine SDF-1 and its receptor …

[引用][C] Attenuation of Obliterative Bronchiolitis by a CXCR4 Antagonist in the Murine Heterotopic Tracheal Transplant Model

J XU, E TORRES, AL MORA, H SHIM… - The Journal of heart …, 2008 - pascal-francis.inist.fr
Attenuation of Obliterative Bronchiolitis by a CXCR4 Antagonist in the Murine Heterotopic
Tracheal Transplant Model CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[HTML][HTML] Attenuation of Obliterative Bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model

J Xu, E Torres, A Mora, H Shim, A Ramirez… - The Journal of heart …, 2008 - ncbi.nlm.nih.gov
Long-term success in lung transplantation is limited by obliterative bronchiolits (OB), while
the mechanism for this disease is not well-understood. Chemokine SDF-1 and its receptor …

Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model.

J Xu, E Torres, AL Mora, H Shim, A Ramirez… - The Journal of Heart …, 2008 - europepmc.org
Background Long-term success in lung transplantation is limited by obliterative bronchiolitis
(OB), yet the mechanism for this disease is not well understood. Chemokine SDF-1 and its …

Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model

J Xu, E Torres, AL Mora, H Shim… - The Journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Long-term success in lung transplantation is limited by obliterative bronchiolitis
(OB), yet the mechanism for this disease is not well understood. Chemokine SDF-1 and its …

Attenuation of Obliterative Bronchiolitis by a CXCR4 Antagonist in the Murine Heterotopic Tracheal Transplant Model

J Xu, E Torres, AL Mora, H Shim… - Journal of Heart …, 2008 - ohiostate.elsevierpure.com
Background: Long-term success in lung transplantation is limited by obliterative bronchiolitis
(OB), yet the mechanism for this disease is not well understood. Chemokine SDF-1 and its …